Early Diagnosis and Treatment of Rheumatoid Arthritis

被引：265

作者：

Littlejohn, Emily A. ^{[1
]}

Monrad, Seetha U. ^{[2
]}

机构：

[1] Cleveland Clin, Orthopaed & Rheumatol Inst, Rheumatol & Immunol Dis, 9500 Euclid Ave,A50, Cleveland, OH 44195 USA

[2] Michigan Med, Div Rheumatol, 7D08 North Ingalls Bldg,300 North Ingalls St, Ann Arbor, MI 48109 USA

来源：

PRIMARY CARE | 2018年 / 45卷 / 02期

关键词：

Rheumatoid arthritis; Synovitis; Extra-articular manifestations; Diagnostic criteria; Disease-modifying antirheumatic drugs; Biologic agents; CYCLIC CITRULLINATED PEPTIDE; DOUBLE-BLIND; PLUS METHOTREXATE; THERAPY; DISEASE; COMBINATION; ANTIBODIES; MORTALITY; EROSIONS; COHORT;

D O I：

10.1016/j.pop.2018.02.010

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Rheumatoid arthritis is the most common inflammatory arthritis and a significant cause of morbidity and mortality. Primary care providers should be able to distinguish the clinical presentation of rheumatoid arthritis from that of osteoarthritis, because the treatment and outcomes differ greatly between these 2 common forms of arthritis. This article provides a current overview of our understanding of rheumatoid arthritis, with an emphasis on early diagnosis and approaches to treatment.

引用

页码：237 / +

页数：20

共 50 条

[31] Biologic monotherapy as initial treatment in patients with early rheumatoid arthritis
Gomez-Reino, Juan
RHEUMATOLOGY, 2012, 51 : V31 - V37
[32] Investigation of Rheumatoid Arthritis Genetic Susceptibility Markers in the Early Rheumatoid Arthritis Study Further Replicates the TRAF1 Association with Radiological Damage
Viatte, Sebastien
Plant, Darren
Lunt, Mark
Fu, Bo
Flynn, Edward
Parker, Ben J.
Galloway, James
Solymossy, Csilla
Worthington, Jane
Symmons, Deborah P. M.
Dixey, Josh J.
Young, Adam
Barton, Anne
JOURNAL OF RHEUMATOLOGY, 2013, 40 (02) : 144 - 156
[33] GENERAL PRINCIPLES FOR TREATMENT OF EARLY RHEUMATOID ARTHRITIS
Henrique da Mota, Licia Maria
Magalhaes Laurindo, Ieda Maria
dos Santos Neto, Leopoldo Luiz
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2010, 56 (03): : 360 - 362
[34] The importance of early treatment for the prognosis of rheumatoid arthritis
Kyburz, Diego
Finckh, Axel
SWISS MEDICAL WEEKLY, 2013, 143
[35] Multifunctional DNA nanomaterials: a new frontier in rheumatoid arthritis diagnosis and treatment
Zhang, Yiyi
Sun, Yue
Liao, Hang
Shi, Sirong
NANOSCALE, 2025, 17 (09) : 4974 - 4999
[36] Biologics for Early Rheumatoid Arthritis
Krueger, K.
AKTUELLE RHEUMATOLOGIE, 2013, 38 (01) : 25 - 29
[37] Remission in Early Rheumatoid Arthritis
Ma, Margaret H. Y.
Scott, Ian C.
Kingsley, Gabrielle H.
Scott, David L.
JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1444 - 1453
[38] Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis
Trouw, Leendert A.
Mahler, Michael
AUTOIMMUNITY REVIEWS, 2012, 12 (02) : 318 - 322
[39] Determining Best Practices in Early Rheumatoid Arthritis by Comparing Differences in Treatment at Sites in the Canadian Early Arthritis Cohort
Harris, Jamie A.
Bykerk, Vivian P.
Hitchon, Carol A.
Keystone, E. C.
Thorne, J. Carter
Boire, Gilles
Haraoui, Boulos
Hazlewood, Glen
Bonner, Ashley J.
Pope, Janet E.
JOURNAL OF RHEUMATOLOGY, 2013, 40 (11) : 1823 - 1830
[40] Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis
Cutolo, Maurizio
Soldano, Stefano
Paolino, Sabrina
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (04) : E42 - U13

← 1 2 3 4 5 →